Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Importance: Treatment-resistant major depression (TRMD) in veterans is a major clinical challenge given the high risk for suicidality in these patients. Repetitive transcranial magnetic stimulation (rTMS) offers the potential for a novel treatment modality for these veterans. Objective: To determine the efficacy of rTMS in the treatment of TRMD in veterans. Design, Setting, and Participants: A double-blind, sham-controlled randomized clinical trial was conducted from September 1, 2012, to December 31, 2016, in 9 Veterans Affairs medical centers. A total of 164 veterans with TRD participated. Interventions: Participants were randomized to either left prefrontal rTMS treatment (10 Hz, 120% motor threshold, 4000 pulses/session) or to sham (control) rTMS treatment for up to 30 treatment sessions. Main Outcomes and Measures: The primary dependent measure of the intention-to-treat analysis was remission rate (Hamilton Rating Scale for Depression score ≤10, indicating that depression is in remission and not a clinically significant burden), and secondary analyses were conducted on other indices of posttraumatic stress disorder, depression, hopelessness, suicidality, and quality of life. Results: The 164 participants had a mean (SD) age of 55.2 (12.4) years, 132 (80.5%) were men, and 126 (76.8%) were of white race. Of these, 81 were randomized to receive active rTMS and 83 to receive sham. For the primary analysis of remission, there was no significant effect of treatment (odds ratio, 1.16; 95% CI, 0.59-2.26; P = .67). At the end of the acute treatment phase, 33 of 81 (40.7%) of those in the active treatment group achieved remission of depressive symptoms compared with 31 of 83 (37.4%) of those in the sham treatment group. Overall, 64 of 164 (39.0%) of the participants achieved remission. Conclusions and Relevance: A total of 39.0% of the veterans who participated in this trial experienced clinically significant improvement resulting in remission of depressive symptoms; however, there was no evidence of difference in remission rates between the active and sham treatments. These findings may reflect the importance of close clinical surveillance, rigorous monitoring of concomitant medication, and regular interaction with clinic staff in bringing about significant improvement in this treatment-resistant population. Trial Registration: ClinicalTrials.gov Identifier: NCT01191333.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092
Self-citationKeller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D., & Gilbody, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100100 · Cited by 565
Dobson, K. S., Hollon, S. D., Dimidjian, S., Schmaling, K. B., Kohlenberg, R. J., Gallop, R. J., Rizvi, S. L., Gollan, J. K., Dunner, D. L., & Jacobson, N. S. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.468 · Cited by 560
Lisanby, S. H., Husain, M. M., Rosenquist, P. B., Maixner, D., Gutierrez, R., Krystal, A., Gilmer, W., Marangell, L. B., Aaronson, S., Daskalakis, Z. J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.118 · Cited by 333
Self-citationBehavioural activation for depression
Veale, D. (2008) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004051 · Cited by 282
Mohamed, S., Johnson, G. R., Chen, P., Hicks, P. B., Davis, L. L., Yoon, J., Gleason, T. C., Vertrees, J. E., Weingart, K., Tal, I., et al. (2017) · JAMA · doi:10.1001/jama.2017.8036 · Cited by 159
Self-citationPTSD Psychotherapy Outcome Predicted by Brain Activation During Emotional Reactivity and Regulation
Fonzo, G. A., Goodkind, M. S., Oathes, D. J., Zaiko, Y. V., Harvey, M., Peng, K. K., Weiss, M. E., Thompson, A. L., Zack, S. E., Lindley, S. E., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16091072 · Cited by 149
Self-citation
Cited by
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070720 · Cited by 802
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
Cole, E. J., Phillips, A. L., Bentzley, B. S., Stimpson, K. H., Nejad, R., Barmak, F., Veerapal, C., Khan, N., Cherian, K., Felber, E., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20101429 · Cited by 795
Distinct symptom-specific treatment targets for circuit-based neuromodulation
Siddiqi, S. H., Taylor, S. F., Cooke, D., Pascual-Leone, A., George, M. S., & Fox, M. D. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19090915 · Cited by 375
Self-citationThe prefrontal cortex, pathological anxiety, and anxiety disorders
Kenwood, M. M., Kalin, N. H., & Barbas, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01109-z · Cited by 312
Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease
Siddiqi, S. H., Schaper, F. L. W. V. J., Horn, A., Hsu, J., Padmanabhan, J. L., Brodtmann, A., Cash, R. F. H., Corbetta, M., Choi, K. S., Dougherty, D. D., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01161-1 · Cited by 296
Self-citationTheta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder
Philip, N. S., Barredo, J., Aiken, E., Larson, V., Jones, R. N., Shea, M. T., Greenberg, B. D., & van ’t Wout-Frank, M. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101160 · Cited by 183
The Insula: A Brain Stimulation Target for the Treatment of Addiction
Ibrahim, C., Rubin-Kahana, D. S., Pushparaj, A., Musiol, M., Blumberger, D. M., Daskalakis, Z. J., Zangen, A., & Le Foll, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00720 · Cited by 133
“However, there is also a large number of studies that found no beneficial effect of TMS for depression (Boutros et al., 2002; Loo et al., 2003; Carpenter et al., 2017; Yesavage et al., 2018), as well as meta-analyses (Martin et al.”
BackgroundJones, B. D. M., Razza, L. B., Weissman, C. R., Karbi, J., Vine, T., Mulsant, L. S., Brunoni, A. R., Husain, M. I., Mulsant, B. H., Blumberger, D. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25531 · Cited by 121
Siddiqi, S. H., Trapp, N. T., Hacker, C. D., Laumann, T. O., Kandala, S., Hong, X., Trillo, L., Shahim, P., Leuthardt, E. C., Carter, A. R., et al. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5889 · Cited by 106
Trapp, N. T., Purgianto, A., Taylor, J. J., Singh, M. K., Oberman, L. M., Mickey, B. J., Youssef, N. A., Solzbacher, D., Zebley, B., Cabrera, L. Y., et al. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.12.015 · Cited by 89
Fitzgerald, P. B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.067 · Cited by 69
Targeting location relates to treatment response in active but not sham rTMS stimulation
Rosen, A. C., Bhat, J. V., Cardenas, V. A., Ehrlich, T. J., Horwege, A. M., Mathalon, D. H., Roach, B. J., Glover, G. H., Badran, B. W., Forman, S. D., et al. (2021) · Brain Stimulation · doi:10.1016/j.brs.2021.04.010 · Cited by 55
“This work was supported by Cooperative Studies Grant # 556 (DHM, BJR, GHG, BWB, SDF, MSG, MT, DYT, YCS, JAY), and Merit Awards #CX000604 (ACR, JB, AMH) and #RX003152 (ACR, VAC) from the United States (U.S.) Department of Veterans Affairs, Office of Research and Development.”
BackgroundMethodSelf-citationMcQuaid, J. R., Buelt, A., Capaldi, V., Fuller, M., Issa, F., Lang, A. E., Hoge, C., Oslin, D. W., Sall, J., Wiechers, I. R., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1603 · Cited by 59
Transcranial magnetic stimulation to reduce suicidality – A review and naturalistic outcomes
Bozzay, M. L., Primack, J., Barredo, J., & Philip, N. S. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.03.016 · Cited by 51
Madore, M. R., Kozel, F. A., Williams, L. M., Green, L. C., George, M. S., Holtzheimer, P. E., Yesavage, J. A., & Philip, N. S. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.025 · Cited by 50
Self-citationLan, X.-J., Yang, X.-H., Mo, Y., Deng, C.-J., Huang, X.-B., Cai, D.-B., & Zheng, W. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104032 · Cited by 32
Adu, M. K., Shalaby, R., Chue, P., & Agyapong, V. I. O. (2022) · Behavioral Sciences · doi:10.3390/bs12060195 · Cited by 31
“(2018) [49] USA A doubleblind, shamcontrolled randomized clinical 18–80 years 164 L-PFC Remission of depression symptoms And the severity of depression symptoms HRSD BDI 3 weeks MagPro R30 device with Cool-B65-A/P coil.”
BackgroundMethodA Systematic Review of Neuromodulation Treatment Effects on Suicidality
Kucuker, M. U., Almorsy, A. G., Sonmez, A. I., Ligezka, A. N., Doruk Camsari, D., Lewis, C. P., & Croarkin, P. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.660926 · Cited by 25
Narapareddy, B. R., Narapareddy, L., Lin, A., Wigh, S., Nanavati, J., Dougherty, J., Nowrangi, M., & Roy, D. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.04.012 · Cited by 23
Philip, N. S., Ramanathan, D., Gamboa, B., Brennan, M. C., Kozel, F. A., Lazzeroni, L., & Madore, M. R. (2023) · Neuromodulation: Technology at the Neural Interface · doi:10.1016/j.neurom.2022.11.015 · Cited by 21
Oberman, L. M., Exley, S., Philip, N. S., Siddiqi, S. H., Adamson, M. M., & Brody, D. L. (2020) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000628 · Cited by 20
Trapp, N. T., Muller Ewald, V. A., Pace, B. D., Wendt, L., Garrett, L., Penaluna, B., Miller, J., Purgianto, A., van der Plas, E., Magnotta, V. A., et al. (2025) · Transcranial Magnetic Stimulation · doi:10.1016/j.transm.2024.100082 · Cited by 3
“Other TMS depression trials have experienced similarly robust placebo responses, including CBM-iTBS trials (Basavaraju et al., 2021; Chauhan et al., 2021), making detection of an active treatment effect challenging (Jones et al., 2021; Yesavage et al., 2018).”
Metadata
- Authors
- Yesavage, J. A., Fairchild, J. K., Mi, Z., Biswas, K., Davis-Karim, A., Phibbs, C. S., Forman, S. D., Thase, M., Williams, L. M., Etkin, A., O’Hara, R., Georgette, G., Beale, T., Huang, G. D., Noda, A., George, M. S., & for the VA Cooperative Studies Program Study Team
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2018-09-01
- Volume
- 75
- Issue
- 9
- Pages
- 884
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2810982934
- Cited by
- 164
- References
- 10
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.